Tuesday, June 29, 2021

Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia

Fibromyalgia (FM) is a common condition affecting 2-4% of the population that is characterized by widespread pain and a cluster of co-occurring symptoms, including fatigue, sleep disturbances, and cognitive dysfunction.2, 18 Managing FM is challenging due to modest effects of approved fibromyalgia medications17, 30 and limited access to non-pharmacological therapies.4 As medical cannabis has become more available in the US,7 many individuals with FM have reported using cannabis-based medicines for symptom management.

from The Journal of Pain https://ift.tt/368yQiN
via IFTTT

No comments:

Post a Comment